8.29
price down icon1.43%   -0.12
after-market After Hours: 8.00 -0.29 -3.50%
loading

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Forecast

The Bridgebio Oncology Therapeutics Inc (BBOT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $8.29. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBOT Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bridgebio Oncology Therapeutics Inc (BBOT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 56.29 Neutral
STOCH(9,6) 65.63 Neutral
STOCHRSI(14) 86.95 Sell
MACD(12,26) -0.0242 Buy
ADX(14) 16.03 Neutral
William %R -25.09 Neutral
CCI(14) 172.85 Buy
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
7.792
Buy
7.9376
Buy
MA20
7.693
Buy
7.8956
Buy
MA50
8.1266
Buy
8.204
Buy
MA100
8.8408
Sell
8.8488
Sell
MA200
10.42
Sell
10.06
Sell
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, BBOT could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 5 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BBOT, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 56.29 indicates that BBOT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 65.63 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 86.95 indicates that BBOT is oversold. This suggests that BBOT price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 16.03 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 172.85 indicates that BBOT is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Year by Year Forecast

$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
Cap:     |  Volume (24h):